Plasmids encoding various external guide sequences (EGSs) were constructed and inserted into Escherichia coli. In strains harboring the appropriate plasmids, the expression of fully induced 18-galactosidase and alkaline phosphatase activity was reduced by more than 50%, while no reduction in such activity was observed in strains with nonspecific EGSs. The The potential value of ribozymes (e.g., RNase P, hammerhead, hairpin) as therapeutic agents is a direct consequence of their ability to catalyze sequence-specific cleavage of targeted RNAs in vitro (1). To date, the hairpin and hammerhead ribozymes have also been used with some success to cleave specific mRNAs in tissue culture (2-7). Moreover, RNase P from both Escherichia coli and human tissue can inhibit gene expression in mammalian cells in tissue culture (8, 9) . In contrast to experiments with eukaryotic cells, mixed results have been obtained for targeted cleavage by hammerhead ribozymes of mRNAs in E. coli (10-12). We show here that RNase P can be used to regulate the expression of several genes in E. coli.
blot analysis showed that the steady-state copy number ofEGS RNAs was several hundred per cell in vivo. A plasmid that contained a gene for Ml RNA covalently linked to a specific EGS reduced the level of expression of a suppressor tRNA that was encoded by a separate plasmid. Similar methods can be used to regulate gene expression in E. coli and to mimic the properties of cold-sensitive mutants.
The potential value of ribozymes (e.g., RNase P, hammerhead, hairpin) as therapeutic agents is a direct consequence of their ability to catalyze sequence-specific cleavage of targeted RNAs in vitro (1) . To date, the hairpin and hammerhead ribozymes have also been used with some success to cleave specific mRNAs in tissue culture (2) (3) (4) (5) (6) (7) . Moreover, RNase P from both Escherichia coli and human tissue can inhibit gene expression in mammalian cells in tissue culture (8, 9) . In contrast to experiments with eukaryotic cells, mixed results have been obtained for targeted cleavage by hammerhead ribozymes of mRNAs in E. coli (10) (11) (12) . We show here that RNase P can be used to regulate the expression of several genes in E. coli.
The main physiological role of RNase P, an essential enzyme (EC 3.1.26.5), is to cleave precursor tRNAs (ptRNAs) to generate the 5' termini of mature tRNA molecules (13) . The enzyme in E. coli is a ribonucleoprotein in which the RNA moiety (Ml RNA) is the catalytic subunit (14) and the protein subunit (C5 protein) is a necessary cofactor in vivo (15) . We have shown previously that RNase P can specifically cleave any RNA in vitro, provided that the RNA is hybridized to a short oligonucleotide, known as an external guide sequence (EGS), that is complementary to the targeted region (8, 16, 17) , but no similar data have been reported for inhibition of gene expression in E. coli. The use of an E. coli strain that is temperature sensitive for RNase P (18) has allowed us to distinguish between inhibition of targeted gene expression in vivo by the action of RNase III or by antisense interactions with targeted RNA and the inhibition that is due to the activity of RNase P.
MATERIALS AND METHODS
Materials. T4 DNA ligase, the Klenow fragment of DNA polymerase I, and restriction endonucleases were purchased from New England Biolabs; T7 RNA polymerase and RNasin were purchased from Promega; rapid hybridization buffer and radiolabeled chemicals were from Amersham; and Sequenase was from United State.s Biochemical.
Bacterial Strains. In this study we used BL21 (DE3), FompT[lonlhsdSB, r-m-(a strain of E. coli B) with DE3, a A prophage that carries the gene for T7 RNA polymerase (19) ; BL21(DE3)A49, which is similar to NHY322, A(proB-lac), ara, gyrA, thi, zic-501::TnlO, rnpA49 (20, 21) ; and E. Cali PP113(A49), recA, lacZam, rnpA49 (18) . T7A49 was constructed by phage P1 transduction with NHY322 as the donor and BL21(DE3) as the recipient, with selection not only for tetracycline resistance (TetR) and temperature sensitivity (the donor's markers) but also for f3-galactosidase and T7 RNA polymerase activity (the recipient's markers).
Plasmids. To construct genes for EGSs under the control of phage T7 RNA polymerase, inserts were cloned into pUC19 that lacked a Pvu II-Pvu II fragment of 322 bp. DNA oligonucleotides containing the sequences for the T7 promoter, the various EGSs used, and a hammerhead core of 57 nucleotides (CCAGGUCACCGGAUGUGCUUUCCGGUCUGAUGA-GUCCGUGAGGACGAAACCUGGAUC; the underlined sequence is the 3' terminus of the EGS) were ligated'to a BamHI-HindIII fragment that contained the T7 terminator sequence. This DNA fragment was obtained from pET3040 (22) . Plasmid DNAs that contained the new inserts were obtained from transformants and subjected to sequence analysis to verify that the expected sequences were present. The following plasmids were obtained: pNT7DSlHH (coding for DS1-EGS, directed against f3-galactosidase mRNA); pNT7APHH (coding for AP-EGS, directed against alkaline phosphatase mRNA); and pNT7CIHH and pNT7NHH (coding for EGSs directed against phage A CI'and N mRNAs, respectively). Plasmid pBRCCA was a generous gift from N. B. 
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incubated at 30°C and the other half was incubated at 43°C for 1 further hour. Cell growth was stopped by placing the cultures on ice. Three aliquots were taken from each culture: one for assays of ,B-galactosidase and alkaline phosphatase activities, one for assays of RNase P, and one for extraction of RNA.
In experiments in which tRNATyrsuI was targeted, E. coli PP113(A49) (which contained a lacZam mutation) was transformed with two plasmids: the first, pACSu', encoded a functional tRNATYrsuI; and the second was chosen to express different Ml-EGS (or mutant Mi-EGS) RNAs. All RNAs were transcribed by E. coli RNA polymerase. Overnight cultures in LBACAP (LB medium supplemented with ampicillin at 100 jig/ml and chloramphenicol at 50 ,ug/ml) were diluted to OD6co = 0.05 in LBACAP and IPTG (2 mM, final concentration) and were incubated at 30°C for about 3 h. The cultures were then divided and one half of each culture was incubated at 30°C and the other half at 43°C for 1 further hour. Cell growth was stopped by placing the cultures on ice. Two aliquots were taken from each culture: one for assays of ,B-galactosidase and RNase P and one for extraction of RNA.
Assays for 18-Galactosidase and for Alkaline and Acid Phosphatases. Assays for ,B-galactosidase were performed at 28°C in Z buffer (60 mM Na2HPO4/40 mM NaH2PO4/10 mM KCl/1 mM MgSO4/50 mM 2-mercaptoethanol) as described by Miller (24) . Alkaline phosphatase activity was measured at 37°C in 200 mM Tris HCl, pH 8.0, with the substrate, p-nitrophenyl phosphate (NPP), at 0.8 mg/ml. Acid phosphatase activity was measured at 37°C in 200 mM NaOAc, pH 4.0, with NPP as substrate at 0.8 mg/ml. All reactions were terminated by the addition of 1 M Na2CO3 (0.75 M, final). Assays for RNase P Activity. One-milliliter aliquots of cell cultures were harvested and the cell pellets were resuspended with 100 ,ul of buffer A (50 mM Tris-HCl, pH 7.5/100 mM NH4Cl/10 mM MgCl2) and placed on ice. Then 5 ,ul of a solution of lysozyme (10 mg/ml) was added and the samples were kept on ice for about 30 min. Protein (0.1 ,g) from such crude extracts was used for assays of RNase P with the precursor to tRNATYr as substrate (25) .
Northern Blots and Dot Blots. Total RNA extracted from cells was subjected to electrophoresis on an 8% polyacrylamide gel that contained 7 M urea. Bands of RNA were stained with ethidium bromide and the gel was soaked in transfer buffer (10 mM Tris acetate, pH 7.8/5 mM sodium acetate/i mM EDTA) for about 20 min. The bands of RNAs were then electrotransferred to a nylon membrane over the course of 12-15 h at 250 mA (26) . After transfer, the RNA was crosslinked to the membrane with a Stratalinker (Stratagene). Hybridization was performed in rapid hybridization buffer (Amersham) by the protocol from Amersham. Northern blots were used to measure the steady-state levels of EGSs in vivo. Levels of mRNA in cells were determined by dot-blot assays, as described by Yarchuk et al. (27) . To correct for dot-to-dot variations, 5S RNA was used as the internal control. RNA samples were placed on nylon membranes and crosslinked to membranes with the Stratalinker. The hybridization procedure was similar to that used for Northern blots.
RESULTS
Strategy for Construction of Strains. To distinguish inhibition of gene expression due to RNase P activity from inhibition due to antisense oligonucleotide interaction or RNase III activity, we transformed E. coli strains that were temperaturesensitive for RNase P with plasmids that expressed specific and nonspecific EGSs. If RNase P activity were primarily responsible for inhibition of the expression of the targeted gene, no inhibition in cells incubated at 43°C, a treatment that inactivates RNase P, would be observed. All EGSs were cloned under control of the phage T7 promoter control and each EGS sequence was followed by a hammerhead (HH) sequence and a T7 terminator, as described in Materials and Methods. The hammerhead sequence was inserted to ensure that, after transcription, the long transcripts would self-cleave and generate EGSs that contained only four nucleotides after the 3'-terminal CCA sequence. The short EGSs would then function to guide the cleavage of specific mRNAs. (The efficiency of cleavage of substrates by RNase P is significantly reduced when the substrate contains a long 3'-flanking sequence.) BL21(DE3)A49 (21, 28), a thermosensitive derivative of BL21(DE3) that carried the temperature-sensitive A49 mutation in the rnpA gene, was designated as a recipient of different plasmids that contained genes for EGSs. The mRNA for the lacZ gene was chosen as a target because it allowed a direct comparison of the results obtained in vivo with those previously obtained in vitro (17) . In preliminary experiments we found, however, that BL21(DE3)A49 did not have the lacZ+ marker or the gene for T7 RNA polymerase. Accordingly, to generate transcripts of the genes for EGSs in the rnpA background, we constructed the strain T7A49 (see Materials and Methods), in which both the lacZ+ gene and the gene for T7 RNA polymerase were present. The EGSs in T7A49 targeted not only the mRNA for B3-galactosidase but also the mRNA for alkaline phosphatase. [Unlike the induction of f3-galactosidase, the induction of the synthesis of EGS was independent of the induction of mRNA for alkaline phosphatase. Alkaline phosphatase is a reasonably stable enzyme and can be easily assayed colorimetrically (23) .] Controls included plasmids with EGSs targeted to phage A N (pNT7NHH) and CI (pNT7CIHH) mRNAs.
Inhibition of Gene Expression by Chromosomal RNase P. Inhibition of alkaline phosphatase or /3-galactosidase activity in vivo by using the EGS technology was dependent on the activity of RNase P (Tables 1 and 2 ). As expected, the extent of inhibition was much lower in cells incubated at nonpermissive temperature (0-11%) as compared with permissive temperature (50-60%). To confirm that the inhibition observed was specific to the targeted message, levels of acid phosphatase activity were also measured and compared to the results for alkaline phosphatase and ,B-galactosidase. Untargeted acid phosphatase activity remained at about the same level in all the cultures examined. In fact, the levels of inhibition were similar when either cell density or acid phosphatase activity was used as a standardization factor. The results summarized in Tables  1 and 2 show that RNase P was capable of reducing the level of expression of fully induced genes specifically but not down to the basal levels of gene expression.
RNase III can cleave double-stranded RNA complexes formed by mRNAs and the corresponding EGSs (17) . In our present studies, the inhibition of gene expression due to cleavage by RNase III, as well as inhibition due to antisense interaction, was seen to be negligible when a comparison was made of the values obtained from cultures grown at permissive and nonpermissive temperature. Indeed, if the observed inhibition had been due to antisense and/or RNase III activity, the extent of inhibition should have been much higher at 43°C than at 30°C because the amounts of EGSs produced at 43°C were 5-to 8-fold higher than those produced at 30°C (see Fig. 1 and Table 3 ). Although our assays indicate that no RNase P activity was detectable in extracts made of cells that had been incubated at 43°C, a low level of inhibition was observed at this temperature in a few experiments. This inhibition might have been due to residual RNase P activity present when the cells were transferred from 30°C to 43°C, since earlier experiments (28, 29) showed that cells with the rnpA49 mutation, when transformed with plasmids that harbored the gene for Ml RNA, were able to grow at nonpermissive temperatures. However, when crude extracts of cells grown at 30°C and 43°C were assayed for RNase P activity in vitro, virtually no activity was found in the extracts of cells grown at the nonpermissive temperature, even in the presence of high concentrations of Ml RNA. Parallel experiments indicated that overproduction of C5 protein rescued RNase P activity at the nonpermissive temperature (data not shown).
Expression of EGSs in Vivo. To study the relative steadystate levels of EGSs required for inhibition of gene expression, levels of EGSs were estimated by Northern blot analysis. As shown in Fig. 1 Right, the efficiency of self-cleavage of the transcript of the EGS targeted to the gene for alkaline phosphatase (AP-EGS) by the hammerhead ribozyme was very high because most of the EGS detected on Northern blots had the mobility of the EGS without the HH sequence. Similar results were obtained with the ,B-galactosidase-specific EGS (DS1-EGS; data not shown).
Ml RNA could not be used as an internal control to calculate the amounts of EGSs produced by the rnpA cells because the amount of Ml RNA produced at the nonpermissive temperature was much lower than that produced by the cells at 30°C (Table 3 ). In wild-type cells, such a decrease was not observed (data not shown). Therefore, the intracellular amount of 5S RNA (30) was used as an internal control. The amount of 5S RNA produced was about the same in cultures that overexpressed AP-EGS RNA (Fig. 1 Left) at both temperatures.
To correlate the overproduction of EGSs with the extent of inhibition of the targeted enzyme, EGS was induced for 30 min before induction of the gene for alkaline phosphatase: the extent of inhibition at 30°C varied from 54.7% (obtained with simultaneous induction of EGS and alkaline phosphatase) to 68%. In cultures incubated at 43°C, the extent of inhibition after 30-min preinduction of EGS was 0% (it was 4.7% for coinduction of EGS and alkaline phosphatase). These experiments could not be performed with /3-galactosidase because both the EGS and the mRNA were induced by IPTG. Estimates of the steady-state copy numbers of EGSs, ranging from about 100 to 600 and depending on the growth temperature, are shown in Table 3 .
mRNA Copy Number. To determine intracellular levels of mRNAs, dot-blot assays were performed, using specific complementary EGSs as probes, with the foreknowledge that both products of degradation and intact mRNA would be detected in this way. 5S RNA was used as the internal control to normalize dot-to-dot variation. When DS1-EGS was used as a probe in the case of lacZ mRNA, the amount of mRNA was about 50% lower at 30°C than at 43°C, in agreement with the results obtained for f3-galactosidase activity. However, in the case of mRNA for alkaline phosphatase (with AP-EGS used as the probe), no such reduction was observed (Table 3) . A possible explanation for these results is that these two targeted RNAs, either before or after cleavage by RNase P, had different kinetics of degradation at 30°C and 43°C when in a complex with an EGS. Under conditions where maximum inhibition of alkaline phosphatase was achieved, the copy numbers of AP-EGS and alkaline phosphatase mRNA were about equal (Table 3) . Inhibition of Gene Expression by an Ml RNA-EGS Construct. No RNase P activity was detected in extracts of strains carrying the rnpA49 mutation at nonpermissive temperatures, presumably because of the temperature-sensitive mutation in the rnpA gene. We expected, however, to be able to restore RNase P activity at 43°C by transforming strains carrying rnpA49 with a plasmid that harbored the gene for Ml RNA or Ml RNA covalently linked to an EGS (Ml RNA-EGS), since an excess of Ml RNA is known to complement the rnpA49 mutation (29) . Under such conditions, inhibition of targeted mRNA expression should be possible at 43°C. Additionally, recent studies (refs. 9 and 31; Y.L. and S.A., unpublished experiments) have indicated that Ml RNA covalently linked to an EGS can cleave targeted mRNA in vitro even in buffers that contain low concentrations of Mg2+. Accordingly, we determined whether such a construct encoded in a high-copynumber plasmid could be used to inhibit the expression of a (Table 4) , was also known to be inactive in vitro, and this group served, therefore, as a negative control set (nucleotides in the variable loop of the tRNA are more accessible than those in the anticodon loop for hybridization to an EGS oligonucleotide). Strain PP11 13(A49), which contained a lacZ-amber mutation, was transformed with the appropriate plasmids and was used as an indicator of suppressor function. The set of Mi-EGS constructs directed at nucleotide 43 in the tRNA (Table 4) successfully inhibited the expression of the suppressor. Furthermore, the temperaturesensitive derivatives G65 and G106 exhibited the expected phenotypes at 43°C (Table 4) . At the permissive temperature, G65/43-EGS inhibited f3-galactosidase activity more efficiently than the wild-type M1/43-EGS. At reported here, a maximum of about 60% reduction in the levels of fully induced enzymatic expression was observed. Our results indicate also that, if constitutive production of EGSs could be coupled to production of RNase P, the inhibitory potential of our method could be enhanced (see below).
An Ml RNA-EGS construct inhibited the expression of a suppressor tRNA encoded on a low-copy-number plasmid to about the same extent as that achieved with EGSs alone targeted to the mRNAs for alkaline phosphatase and ,3-galactosidase. By contrast, such a construct has been found capable of inhibiting gene expression in mammalian cells in tissue culture by more than 80% (9) . The inability to achieve complete inhibition of gene expression in E. coli may be due to several factors, among which are a limit to the steady-state copy number per cell of EGSs in our constructs and the inaccessibility of a fraction of every population of mRNA due to the tight coupling of transcription and translation in E. coli. Eukaryotic mRNAs expressed in the bacterial cells (10) may not be subject to this tight coupling because of cross-species differences in ribosome-binding sites.
Alkaline phosphatase and /3-galactosidase activities are stimulated in cells that overexpress Ml RNA (data not shown), an indication that RNase P (and Ml RNA specifically) could play a role in transcription or translation, possibly by cleavage of mRNA with consequent more efficient translation. Such a phenomenon has been observed with mRNA of the histidine operon in Salmonella typhimurium (33) . Overproduction of Ml RNA in T7A49 also increases the level of RNase P and could cause the biosynthesis of larger amounts of mature tRNA, thereby increasing the efficiency of translation. In BL21(DE3), which is wild-type for RNase P, such a stimulation of translation should be negligible. Indeed, in the wild-type background, the levels of f3-galactosidase activity were similar for all controls, regardless of the presence or absence of overproduced Ml RNA (data not shown), an indication that, in T7A49 cells, even at the permissive temperature, RNase P activity can be limiting. Our general method, however, may be useful for altering levels of resistance to antibiotics and other drugs, as well as for studies of the basic function of genes in prokaryotes.
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